Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06999291 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ovarian Reserve in Intensive Care Patients

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 31, 2025 (before its estimated July 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Gastrointestinal, pulmonary, nephrological, cardiac, neurologic and psychological effects in critically ill patients followed in the intensive care unit have been shown in the literature. However, the effects on ovarian reserve in these patients have not been sufficiently investigated and studies investigating this issue are limited in the literature. The synthesis, release frequency and amplitude of reproductive hormones change under stress. In addition, changes in ovarian homeostasis affect ovarian reserve. The aim of this study was to evaluate ovarian reserve in critically ill patients followed up in the intensive care unit.
Trial Details
NCT Number NCT06999291
Lead Sponsor Haseki Training and Research Hospital
Conditions
(from sponsor)		 Anti-Mullerian Hormone Deficiency
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov